{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T09:43:35.9962+00:00","published_at":"2026-10-17T04:45:23.017038+00:00","section":"leadership","data":{"state":"PUBLISHED","executives":[{"person":{"alpha_id":"alpha:person:bryan-andrew-supran","name":"Bryan Andrew Supran","canonical_url":"https://registry.alpha.ac/people/bryan-andrew-supran"},"title":"Chief Legal Officer","role_code":"GC","role_code_basis":"title_normalization","status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:caaf2601cc94e41d604b00d102bdb4955d1f666697dc325cf759db3ac6d2178c"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:christine-regan-akinc","name":"Christine Regan Akinc","canonical_url":"https://registry.alpha.ac/people/christine-regan-akinc"},"title":"Chief Corporate Communications Officer","role_code":null,"role_code_basis":null,"status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:4a4e631eca73e2ce2765745a3baca4787a506dcf59398595f2d4ed3f04b10b6b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:jeffrey-v-poulton","name":"Jeffrey V. Poulton","canonical_url":"https://registry.alpha.ac/people/jeffrey-v-poulton"},"title":"Chief Financial Officer","role_code":"CFO","role_code_basis":"title_normalization","status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:19","evidence_ids":["alpha:projection-evidence:document:66929166e6a0f476fa587e7e2e418d1171773a0ba289c729b155db0899cdc9a2"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kevin-joseph-fitzgerald","name":"Kevin Joseph Fitzgerald","canonical_url":"https://registry.alpha.ac/people/kevin-joseph-fitzgerald"},"title":"Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development","role_code":null,"role_code_basis":null,"status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:20","evidence_ids":["alpha:projection-evidence:document:615c91c4ec505909807969892579fd26190b40e7c4717785da41bc5ff43ffac1"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:piyush-sharma","name":"Piyush Sharma","canonical_url":"https://registry.alpha.ac/people/piyush-sharma"},"title":"Chief Ethics & Compliance Officer","role_code":null,"role_code_basis":null,"status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:21","evidence_ids":["alpha:projection-evidence:document:c5dd922b446b80300976434eca65da81c1a2ebfb8cbbde856dc753ec0148df1c"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:pushkal-garg","name":"Pushkal Garg","canonical_url":"https://registry.alpha.ac/people/pushkal-garg"},"title":"EVice President of Development & Medical Affairs and Chief Research & Dev. Officer","role_code":null,"role_code_basis":null,"status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:22","evidence_ids":["alpha:projection-evidence:document:27efd1c9a3109e32fa28343cd155f40967f04a8c0754bd215bd8400893b41dd4"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:timothy-j-maines","name":"Timothy J. Maines","canonical_url":"https://registry.alpha.ac/people/timothy-j-maines"},"title":"Chief Technical Operations & Quality Officer","role_code":null,"role_code_basis":null,"status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:23","evidence_ids":["alpha:projection-evidence:document:66e740ddd0a350cff007fa41446902f9d16474055dc6e089204a1f51764d2287"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:tolga-tanguler","name":"Tolga Tanguler","canonical_url":"https://registry.alpha.ac/people/tolga-tanguler"},"title":"Executive VP & Chief Commercial Officer","role_code":null,"role_code_basis":null,"status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":false,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:24","evidence_ids":["alpha:projection-evidence:document:7cf0fa28fdb6e14f9fcdb07d26475348a6326ef19fe262cc43cf41d55f8b787a"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yvonne-l-greenstreet-2","name":"Yvonne L. Greenstreet","canonical_url":"https://registry.alpha.ac/people/yvonne-l-greenstreet-2"},"title":"President and Chief Executive Officer","role_code":"CEO","role_code_basis":"title_normalization","status":"unknown","start_date":null,"end_date":null,"named_executive_officer":null,"board_member":true,"fields_not_published":["reporting_relationship","authority","compensation","equity_ownership","succession_state"],"claim_id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:25","evidence_ids":["alpha:projection-evidence:document:d35b231f7ff1a9f9a75e6507d2fd2606ab46249006484d5b19e13b51db4563e0"],"assertion_class":"source_fact","verification_state":"source_reported"}],"role_coverage":{"CEO":{"alpha_id":"alpha:person:yvonne-l-greenstreet-2","name":"Yvonne L. Greenstreet","canonical_url":"https://registry.alpha.ac/people/yvonne-l-greenstreet-2"},"CFO":{"alpha_id":"alpha:person:jeffrey-v-poulton","name":"Jeffrey V. Poulton","canonical_url":"https://registry.alpha.ac/people/jeffrey-v-poulton"},"GC":{"alpha_id":"alpha:person:bryan-andrew-supran","name":"Bryan Andrew Supran","canonical_url":"https://registry.alpha.ac/people/bryan-andrew-supran"},"CORPORATE_SECRETARY":null,"COO":null,"CHRO":null,"CIO":null,"CTO":null,"CISO":null,"CAIO":null,"CRO":null}},"claims":[{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:17","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:bryan-andrew-supran","object_label":"Bryan Andrew Supran","object_source_name_forms":[],"value":"Bryan Andrew Supran: Chief Legal Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:bryan-andrew-supran","name":"Bryan Andrew Supran"},"title":"Chief Legal Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:caaf2601cc94e41d604b00d102bdb4955d1f666697dc325cf759db3ac6d2178c","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:13.406701+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:18","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christine-regan-akinc","object_label":"Christine Regan Akinc","object_source_name_forms":[],"value":"Christine Regan Akinc: Chief Corporate Communications Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christine-regan-akinc","name":"Christine Regan Akinc"},"title":"Chief Corporate Communications Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:4a4e631eca73e2ce2765745a3baca4787a506dcf59398595f2d4ed3f04b10b6b","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:11.677388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:19","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jeffrey-v-poulton","object_label":"Jeffrey V. Poulton","object_source_name_forms":[],"value":"Jeffrey V. Poulton: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jeffrey-v-poulton","name":"Jeffrey V. Poulton"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:66929166e6a0f476fa587e7e2e418d1171773a0ba289c729b155db0899cdc9a2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALNY executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:13.227197+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:20","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:kevin-joseph-fitzgerald","object_label":"Kevin Joseph Fitzgerald","object_source_name_forms":[],"value":"Kevin Joseph Fitzgerald: Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:kevin-joseph-fitzgerald","name":"Kevin Joseph Fitzgerald"},"title":"Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:615c91c4ec505909807969892579fd26190b40e7c4717785da41bc5ff43ffac1","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:12.108589+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:21","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:piyush-sharma","object_label":"Piyush Sharma","object_source_name_forms":[],"value":"Piyush Sharma: Chief Ethics & Compliance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:piyush-sharma","name":"Piyush Sharma"},"title":"Chief Ethics & Compliance Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:c5dd922b446b80300976434eca65da81c1a2ebfb8cbbde856dc753ec0148df1c","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:14.305037+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:22","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:pushkal-garg","object_label":"Pushkal Garg","object_source_name_forms":[],"value":"Pushkal Garg: EVice President of Development & Medical Affairs and Chief Research & Dev. Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:pushkal-garg","name":"Pushkal Garg"},"title":"EVice President of Development & Medical Affairs and Chief Research & Dev. Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:27efd1c9a3109e32fa28343cd155f40967f04a8c0754bd215bd8400893b41dd4","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:12.543583+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:23","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:timothy-j-maines","object_label":"Timothy J. Maines","object_source_name_forms":[],"value":"Timothy J. Maines: Chief Technical Operations & Quality Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:timothy-j-maines","name":"Timothy J. Maines"},"title":"Chief Technical Operations & Quality Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:66e740ddd0a350cff007fa41446902f9d16474055dc6e089204a1f51764d2287","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:14.750026+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:24","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:tolga-tanguler","object_label":"Tolga Tanguler","object_source_name_forms":[],"value":"Tolga Tanguler: Executive VP & Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:tolga-tanguler","name":"Tolga Tanguler"},"title":"Executive VP & Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:7cf0fa28fdb6e14f9fcdb07d26475348a6326ef19fe262cc43cf41d55f8b787a","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:15.164711+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:25","subject_id":"alpha:company:f95bc419-f349-4b0d-896d-2572577699d0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:yvonne-l-greenstreet-2","object_label":"Yvonne L. Greenstreet","object_source_name_forms":[],"value":"Yvonne L. Greenstreet: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:yvonne-l-greenstreet-2","name":"Yvonne L. Greenstreet"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:23.017038+00:00","sources":[{"id":"alpha:projection-evidence:document:d35b231f7ff1a9f9a75e6507d2fd2606ab46249006484d5b19e13b51db4563e0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALNY executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:13.227197+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:caaf2601cc94e41d604b00d102bdb4955d1f666697dc325cf759db3ac6d2178c","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:13.406701+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4a4e631eca73e2ce2765745a3baca4787a506dcf59398595f2d4ed3f04b10b6b","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:11.677388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:66929166e6a0f476fa587e7e2e418d1171773a0ba289c729b155db0899cdc9a2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALNY executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:13.227197+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:615c91c4ec505909807969892579fd26190b40e7c4717785da41bc5ff43ffac1","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:12.108589+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c5dd922b446b80300976434eca65da81c1a2ebfb8cbbde856dc753ec0148df1c","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:14.305037+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:27efd1c9a3109e32fa28343cd155f40967f04a8c0754bd215bd8400893b41dd4","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:12.543583+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:66e740ddd0a350cff007fa41446902f9d16474055dc6e089204a1f51764d2287","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:14.750026+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7cf0fa28fdb6e14f9fcdb07d26475348a6326ef19fe262cc43cf41d55f8b787a","identity_scope":"source_document_reference","source_type":"other","title":"Alnylam Pharmaceuticals key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_date":"2026-04-24","retrieved_at":"2026-04-24T06:25:15.164711+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d35b231f7ff1a9f9a75e6507d2fd2606ab46249006484d5b19e13b51db4563e0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ALNY executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:13.227197+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.8,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.695,"cross_source_agreement":0.75,"temporal_completeness":0.423},"diagnostics":{"published_claims":33,"factual_claims":33,"claims_with_linked_evidence":33,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":26,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:23.017038+00:00","observed_at":"2026-10-17T04:45:23.017038+00:00","reviewed_at":"2026-10-17T04:45:23.017038+00:00","verified_at":"2026-10-17T04:45:23.017038+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":33,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/alnylam-pharmaceuticals-inc/leadership","section":"leadership","href":"https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record&section=leadership","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}